The U. S. Food and Drug Administration (FDA), along with the Centers for Disease Control and Prevention (CDC), has advised that the diet pill OxyElite Pro, distributed by USPLabs LLC of Dallas, Texas, may be linked to a risk of serious injury. The Hawaii Department of Health has reported 24 cases of non-viral hepatitis sharing a link to the supplement. Eleven cases of hepatitis have included the user being hospitalized, two cases involve liver transplants, and one person has died. According to the CDC, symptoms of hepatitis can include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay or gray-colored bowel movements, joint pain, yellow eyes, and jaundice. Epidemiological investigation is underway by the Hawaii Department of Health and the CDC.
Of particular concern has been the inclusion of dimethylamylamine (DMAA), which comes from geranium extract, and is used in a variety of health supplements, especially those intended to increase weight loss. The FDA has previously warned that supplements containing DMAA may be linked to serious illness and possibly deaths.
More from the FDA on this topic can be followed here: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370857.htm
USPLabs LLC has issued a statement concerning OxyElite Pro contained here: https://www.huffpost.com/entry/oxyelite-pro-hawaii-liver-failure_n_4066158?ncid=edlinkusaolp00000003
If you believe that you have been injured taking supplements with DMAA, contact us to discuss your case.
